Literature DB >> 16982601

Growth without growth hormone (GH): a case report.

Polyzois Makras1, Dimitris Papadogias, Grigoris Kaltsas, Nikolaos Kaklas, Georgios Piaditis.   

Abstract

Growth without growth hormone (GH) has occasionally been described in patients with organic pituitary pathology, and even more rarely in patients with idiopathic pituitary hormone deficiency. The mechanism of growth without GH remains a mystery. We describe a 17-year old male who grew 38.5 cm in height over a 7-year period, despite the fact that he had established panhypopituitarism. The hypopituitarism was initially attributed to a presumptive hypothalamic hamartoma which was not, however, confirmed on subsequent and prolonged follow-up. Regular endocrine evaluation confirmed persistent anterior and posterior pituitary hormonal deficiencies with severe concomitant hyperinsulinemia as shown by an exaggerated insulin response to a standard oral glucose tolerance test. In our patient, a postulated mechanism could be the severe hyperinsulinemia, acting either through the insulin and/or IGF receptors and thus potentiating the mitogenic effect. This case illustrates that final height attainment within or above target height may occur in patients with idiopathic pituitary hormonal deficiency despite persistent, severe GH insufficiency.

Entities:  

Year:  2004        PMID: 16982601     DOI: 10.14310/horm.2002.11135

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  2 in total

1.  Distinctive growth pattern in a patient with a delayed diagnosis of Langerhans' cell histiocytosis.

Authors:  Athanasios D Anastasilakis; Gregory A Kaltsas; Georgios Delimpasis; Ludwig Wilkens; George Kanakis; Polyzois Makras
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

2.  Untreated hypopituitarism due to absence of the pituitary stalk with normal adult height: report of two cases.

Authors:  Leda Papastathopoulou; Marinella Tzanela; Vania Vlassopoulou; Dimitra Vassiliadi; Nikolaos Thalassinos
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.